Palleiko Benjamin L — SEC Form 4 filings
SEC reporting owner CIK 1366244. 35 Form 4 filings on record with FilingPulse; latest filed 2026-06-11.
Transaction summary — filings shown
Covers all 35 filings on record, filed 2024-02-13 to 2026-06-11. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 29 legs across 29 filings — 297,120 shares, $4,288,518 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 94.
- Largest priced transaction: sale of 40,855 shares @ $15.01 ($613,205) in KalVista Pharmaceuticals, Inc., filed 2024-02-16.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| KalVista Pharmaceuticals, Inc. (KALV) | CHIEF EXECUTIVE OFFICER, Director | 35 | — | 29 legs · 297,120 sh · $4,288,518 | 94 |
Form 4 filings — Palleiko Benjamin L
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-11 | 4 | KalVista Pharmaceuticals, Inc. (KALV) | Disposition to issuer (D): 479,989 @ $0 · Disposition to issuer (D): 47,354 (derivative) · Disposition to issuer (D): 29,611 (derivative) · Disposition to issuer (D): 33,800 (derivative) · Disposition to issuer (D): 71,700 (derivative) · Disposition to issuer (D): 52,600 (derivative) · +12 more | EDGAR |
| 2026-05-26 | 4 | KalVista Pharmaceuticals, Inc. (KALV) | Option exercise (M): 23,250 · Sale (S): 10,926 @ $26.78 · Option exercise (M): 23,250 (derivative) @ $0 | EDGAR |
| 2026-05-19 | 4 | KalVista Pharmaceuticals, Inc. (KALV) | Option exercise (M): 2,419 · Sale (S): 1,129 @ $26.76 · Option exercise (M): 2,419 (derivative) @ $0 | EDGAR |
| 2026-05-13 | 4 | KalVista Pharmaceuticals, Inc. (KALV) | Option exercise (M): 7,120 · Sale (S): 3,322 @ $26.71 · Option exercise (M): 7,120 (derivative) @ $0 | EDGAR |
| 2026-04-20 | 4 | KalVista Pharmaceuticals, Inc. (KALV) | Option exercise (M): 20,312 · Sale (S): 9,550 @ $20.22 · Option exercise (M): 20,312 (derivative) @ $0 | EDGAR |
| 2026-03-10 | 4 | KalVista Pharmaceuticals, Inc. (KALV) | Option exercise (M): 15,625 · Sale (S): 6,693 @ $16.08 · Option exercise (M): 15,625 (derivative) @ $0 | EDGAR |
| 2026-02-24 | 4 | KalVista Pharmaceuticals, Inc. (KALV) | Option exercise (M): 23,250 · Sale (S): 10,034 @ $15.57 · Option exercise (M): 23,250 (derivative) @ $0 | EDGAR |
| 2026-02-19 | 4 | KalVista Pharmaceuticals, Inc. (KALV) | Option exercise (M): 2,419 · Sale (S): 1,038 @ $15 · Option exercise (M): 2,419 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | KalVista Pharmaceuticals, Inc. (KALV) | Option exercise (M): 7,120 · Sale (S): 3,354 @ $15.70 · Option exercise (M): 7,120 (derivative) @ $0 | EDGAR |
| 2026-01-21 | 4 | KalVista Pharmaceuticals, Inc. (KALV) | Grant/award (A): 325,000 (derivative) @ $0 | EDGAR |
| 2025-12-09 | 4 | KalVista Pharmaceuticals, Inc. (KALV) | Option exercise (M): 15,625 · Sale (S): 7,294 @ $16.51 · Option exercise (M): 15,625 (derivative) @ $0 | EDGAR |
| 2025-11-26 | 4 | KalVista Pharmaceuticals, Inc. (KALV) | Option exercise (M): 23,250 · Sale (S): 10,940 @ $13.45 · Option exercise (M): 23,250 (derivative) @ $0 | EDGAR |
| 2025-11-19 | 4 | KalVista Pharmaceuticals, Inc. (KALV) | Option exercise (M): 9,364 · Sale (S): 4,466 @ $14.48 · Option exercise (M): 2,419 (derivative) @ $0 · Option exercise (M): 6,945 (derivative) @ $0 | EDGAR |
| 2025-11-13 | 4 | KalVista Pharmaceuticals, Inc. (KALV) | Option exercise (M): 7,120 · Sale (S): 3,328 @ $11.55 · Option exercise (M): 7,120 (derivative) @ $0 | EDGAR |
| 2025-09-09 | 4 | KalVista Pharmaceuticals, Inc. (KALV) | Option exercise (M): 15,625 · Sale (S): 7,294 @ $15.84 · Option exercise (M): 15,625 (derivative) @ $0 | EDGAR |
| 2025-08-25 | 4 | KalVista Pharmaceuticals, Inc. (KALV) | Option exercise (M): 23,250 · Sale (S): 10,940 @ $13.22 · Option exercise (M): 23,250 (derivative) @ $0 | EDGAR |
| 2025-08-19 | 4 | KalVista Pharmaceuticals, Inc. (KALV) | Option exercise (M): 9,362 · Sale (S): 4,409 @ $13.19 · Option exercise (M): 2,418 (derivative) @ $0 · Option exercise (M): 6,944 (derivative) @ $0 | EDGAR |
| 2025-08-13 | 4 | KalVista Pharmaceuticals, Inc. (KALV) | Grant/award (A): 113,920 (derivative) @ $0 · Grant/award (A): 113,920 (derivative) @ $0 | EDGAR |
| 2025-07-10 | 4 | KalVista Pharmaceuticals, Inc. (KALV) | Grant/award (A): 87,500 · Sale (S): 32,979 @ $15.69 | EDGAR |
| 2025-06-10 | 4 | KalVista Pharmaceuticals, Inc. (KALV) | Option exercise (M): 15,625 · Sale (S): 7,169 @ $14.50 · Option exercise (M): 15,625 (derivative) @ $0 | EDGAR |
| 2025-05-23 | 4 | KalVista Pharmaceuticals, Inc. (KALV) | Option exercise (M): 23,250 · Sale (S): 9,999 @ $11.88 · Option exercise (M): 23,250 (derivative) @ $0 | EDGAR |
| 2025-05-20 | 4 | KalVista Pharmaceuticals, Inc. (KALV) | Option exercise (M): 9,364 · Sale (S): 3,808 @ $11.84 · Option exercise (M): 2,419 (derivative) @ $0 · Option exercise (M): 6,945 (derivative) @ $0 | EDGAR |
| 2025-03-10 | 4 | KalVista Pharmaceuticals, Inc. (KALV) | Option exercise (M): 15,625 · Sale (S): 6,669 @ $11.97 · Option exercise (M): 15,625 (derivative) @ $0 | EDGAR |
| 2025-02-25 | 4 | KalVista Pharmaceuticals, Inc. (KALV) | Grant/award (A): 372,000 (derivative) @ $0 | EDGAR |
| 2025-02-19 | 4 | KalVista Pharmaceuticals, Inc. (KALV) | Option exercise (M): 9,363 · Sale (S): 5,104 @ $9.82 · Option exercise (M): 2,419 (derivative) @ $0 · Option exercise (M): 6,944 (derivative) @ $0 | EDGAR |
| 2024-12-09 | 4 | KalVista Pharmaceuticals, Inc. (KALV) | Option exercise (M): 15,625 · Sale (S): 7,627 @ $9.75 · Option exercise (M): 15,625 (derivative) @ $0 | EDGAR |
| 2024-11-19 | 4 | KalVista Pharmaceuticals, Inc. (KALV) | Option exercise (M): 30,198 · Sale (S): 14,400 @ $9.26 · Option exercise (M): 2,419 (derivative) @ $0 · Option exercise (M): 6,945 (derivative) @ $0 · Option exercise (M): 20,834 (derivative) @ $0 | EDGAR |
| 2024-09-10 | 4 | KalVista Pharmaceuticals, Inc. (KALV) | Option exercise (M): 15,625 · Sale (S): 7,352 @ $12.19 · Option exercise (M): 15,625 (derivative) @ $0 | EDGAR |
| 2024-08-21 | 4 | KalVista Pharmaceuticals, Inc. (KALV) | Option exercise (M): 30,195 · Sale (S): 14,215 @ $12.01 · Option exercise (M): 2,418 (derivative) @ $0 · Option exercise (M): 6,944 (derivative) @ $0 · Option exercise (M): 20,833 (derivative) @ $0 | EDGAR |
| 2024-06-10 | 4 | KalVista Pharmaceuticals, Inc. (KALV) | Option exercise (M): 15,625 · Sale (S): 7,465 @ $11.53 · Option exercise (M): 15,625 (derivative) @ $0 | EDGAR |
| 2024-05-21 | 4 | KalVista Pharmaceuticals, Inc. (KALV) | Option exercise (M): 51,031 · Sale (S): 21,959 @ $11.76 · Option exercise (M): 2,419 (derivative) @ $0 · Option exercise (M): 6,945 (derivative) @ $0 · Option exercise (M): 20,834 (derivative) @ $0 · Option exercise (M): 20,833 (derivative) @ $0 | EDGAR |
| 2024-03-08 | 4 | KalVista Pharmaceuticals, Inc. (KALV) | Grant/award (A): 250,000 (derivative) @ $0 | EDGAR |
| 2024-02-21 | 4 | KalVista Pharmaceuticals, Inc. (KALV) | Option exercise (M): 51,029 · Sale (S): 22,802 @ $14.11 · Option exercise (M): 2,419 (derivative) @ $0 · Option exercise (M): 6,944 (derivative) @ $0 · Option exercise (M): 20,833 (derivative) @ $0 · Option exercise (M): 20,833 (derivative) @ $0 | EDGAR |
| 2024-02-16 | 4 | KalVista Pharmaceuticals, Inc. (KALV) | Sale (S): 40,855 @ $15.01 | EDGAR |
| 2024-02-13 | 4 | KalVista Pharmaceuticals, Inc. (KALV) | Grant/award (A): 87,500 · Grant/award (A): 83,333 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1366244 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →